Get notified of page updates

Search Results: (30 results)

New Search

PRINTER FRIENDLY PAGE 331 through 360 of 374

Phase 1/1b Study of Oral Drug PMD-026 in People with Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

PMD-026 is a study for people who have been diagnosed with metastatic triple negative breast cancer (mTNBC) who have no further treatment options. This research study is investigating if a study drug called PMD-026 is safe and effective for patients with mTNBC. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT04115306

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

The purpose of this study is to determine whether the addition of the immunotherapy agent pembrolizumab to radiation therapy is more effective than radiation therapy alone in reducing the risk of cancer recurrence in patients with newly diagnosed stage I-II endometrial cancer that is MSI-High. This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT04214067

A Study of EDP1503 in Patients With Colorectal or Triple Negative Breast Cancer or Cancer That Came Back After Treatment with a Checkpoint Inhibitor

Medicines that affect bacteria in the stomach and intestines may assist immunotherapy agents like pembrolizumab (Keytruda) in treating cancer. This study will look at the effect of a drug, EDP1503 on enhancing the anti-cancer response when used with pembrolizumab, in patients with advanced metastatic colorectal carcinoma, triple-negative breast cancer, or cancers that have recurred after a type of immunotherapy known as an immune checkpoint inhibitor. NOTE: This this study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03775850

People with stage 1-3 cancer

RESTORE: A virtual study comparing 2 digital apps to improve mental and physical well-being of patients with stage I – 3 cancer

Many cancer patients experience cancer-related distress, which includes psychological symptoms of anxiety and depression. The RESTORE study will enroll up to 415 adults who have been diagnosed with stage I-III cancer. The goal is to test how effective two different apps are at improving physical and mental health. Participants use their smartphone or tablet to download and access their assigned treatment app without ever needing to visit a clinic in person.

Clinicaltrials.gov identifier: NCT05227898

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

This is a phase II study looking at different treatment combinations for men with metastatic, castration resistant prostate cancer (mCRPC) to see which is most effective for improving progression free survival (keeping the cancer from progressing). The study will include testing for genes within the tumor to determine eligibility for the study.

Patients with tumors that have ATM, BRCA1 and/or BRCA2 mutations or defects will be randomly assigned to one of the treatment arms of the study. Patients with tumors that have mutations in other DNA repair genes including FANCA, PALB2, RAD51, ERCC3, MRE11, NBN, MLH3, CDK12, CHEK2, HDAC2, ATR, PMS2, GEN1, MSH2, MSH6, BRIP1, or FAM175A will be assigned to Arm IV with single agent olaparib. NOTE: This study is now closed.

Clinicaltrials.gov identifier: NCT03012321

University of Hawai'i Cancer Center: 50 Years of Progress

Mobile Mindfulness Meditation Intervention to Improve Neuropathy in Cancer Survivors

Aloha! The University of Hawai‘i Cancer Center is running a mobile app study to see how it impacts cancer-related neuropathy. We are asking people who have been diagnosed with cancer, have finished primary treatment and are experiencing neuropathy if they would like to use a mobile app for mindfulness meditation to see if it helps their neuropathy.

Interested participants will be asked to follow the link for either anxiety OR neuropathy and to participate in only one of the studies, one time only. Upon enrollment, you will randomly be assigned to begin using the mobile app either immediately or after eight weeks. You will be asked to complete online questionnaires about your well-being upon your initial enrollment, 8 weeks later, and 16 weeks later.

Clinicaltrials.gov identifier: NCT03581357

Niraparib + Ipilimumab or Nivolumab in Pancreatic Cancer that Has Not Progressed After Platinum Chemotherapy (Parpvax)

The purpose of this study is to look at the effectiveness, safety, and anti-cancer activity of the drug Niraparib combined with one of two immunotherapy agents: Ipilimumab or Nivolumab on patients with locally advanced or metastatic pancreatic cancer. Patients in this study must also have previously received Platinum-based chemotherapy without evidence of disease progression. NOTE: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03404960

Parenting Adolescent-Aged Children While Managing a Parental Cancer Diagnosis – Share Your Story

The study explores how families faced with a parental cancer diagnosis communicate, or why they choose not to communicate, with their children about the cancer diagnosis, treatments, and other related topics. At least one family member (diagnosed parent or non-diagnosed parent) is asked to participate, but more than one member can sign up to be interviewed. NOTE: This study is no longer enrolling people.

Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors

Aloha! The University of Hawai‘i Cancer Center is running a mobile app study to see how it impacts different areas of well-being in cancer survivors – namely, anxiety and cancer-related neuropathy. We are asking people who have been diagnosed with cancer and finished primary treatment if they would like to use a mobile app for mindfulness meditation to see if it impacts anxiety.

Interested participants will be asked to follow the link for anxiety. Upon enrollment, you will randomly be assigned to begin using the mobile app either immediately or after eight weeks. You will be asked to complete online questionnaires about your well-being upon your initial enrollment, 8 weeks later, and 16 weeks later.

Clinicaltrials.gov identifier: NCT03581357

Treatment study for people with advanced colorectal, gastric and gastro-esophageal junction tumors

Nous-209 Genetic Vaccine for the Treatment of Microsatellite -High (MSI-H) Colorectal, Gastric and Gastro-esophageal junction Tumors

The goal of this cancer treatment study is to find the best dose and learn how safe and effective this cancer vaccine is for treating advanced colorectal, gastric and gastro-esophageal junction tumors that test positive for the biomarkers MSI-High or dMMR. Participants will receive the vaccine in combination with the immunotherapy drug Keytruda (pembrolizumab).

Clinicaltrials.gov identifier: NCT04041310

A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3)

The purpose of Triton3 is to determine how patients with metastatic castration-resistant prostate cancer, and an inherited gene mutation or tumor genetic deficiency, respond to treatment with the PARP inhibitor rucaparib compared to treatment with physician's choice of abiraterone acetate, enzalutamide, or docetaxel. NOTE: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT02975934

Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS)

Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS) is a national, patient-driven registry for any male who has undergone or is currently undergoing genetic testing for prostate cancer. Note: This study is no longer enrolling.

A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment with Immune Checkpoint Inhibitors (QUILT-3.055)

Immune checkpoint inhibitors immunotherapy drugs that allow the immune system to find and destroy cancer cells.

This study will use a combination of immunotherapies in people who's cancer got worse after treatment with a PD-1 or PD-L1 immune checkpoint inhibitor. NOTE: This study is no longer recruiting.

Clinicaltrials.gov identifier: NCT03228667

Safety and Efficacy of Olaparib Combined with Agents Targeting DNA Damage Repair Compared to Olaparib Alone

The purpose of this study is to assess the efficacy and safety of treatment with the PARP inhibitor, olaparib combined with the drug Ceralasertib compared with olaparib alone for patients with Triple-Negative Breast Cancer.

NOTE: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03330847

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden

This study is researching a combination of two immunotherapy drugs for advanced solid tumors that contain a tumor biomarker known as "High Tumor Mutation Burden" (TMB-H). The researchers are studying whether treatment of these tumors with a combination of the drugs nivolumab plus ipilimumab is safe and effective compared with nivolumab alone. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03668119

A Study of Nivolumab in Selected Uterine Cancer Patients

The purpose of this study is to test the effectiveness, safety, and tolerability of Nivolumab on patients with metastatic or recurrent uterine cancer.

Nivolumab is a type of immunotherapy known as an immune checkpoint inhibitor. Immune checkpoint inhibitors are drugs that prevent cancer cells from switching off immune cells. This allows the immune system to find, unmask and destroy cancer cells. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03241745

GENetic Education Risk Assessment and TEsting Study (GENERATE)

The goal of the GENERATE study is to increase the uptake of genetic testing among family members of pancreatic cancer patients who may carry a genetic mutation.

This study involves education about genetic testing, undergoing genetic testing for cancer risk (for those who choose to) and completion of a series of 4 sets of questionnaires. Note: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03762590

A Study in Advanced Breast Cancer Patients with BRCA 1/2 Mutations Evaluating Olaparib alone or in Combination with Atezolizumab

This is a study for women or men who have been diagnosed with advanced breast cancer with a BRCA 1/2 mutation. The goal of the study is to look at whether giving the PARP inhibitor olaparib in combination with the immunotherapy atezolizumab improves outcomes for patients compared to olaparib alone. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02849496

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02912559

USCF Helen Diller Family Comprehensive Cancer Center

PHACT Study: Population Health and Cancer Testing

NOTE: The PHACT study is no longer recruiting patients.

Pilot Study of Denosumab in BRCA1 or BRCA2 Mutation Carriers Scheduling Risk-Reducing Salpingo-Oophorectomy

The purpose of this study is to evaluate the effects of denosumab on ovarian cancer risk markers among premenopausal women with a BRCA1 or BRCA2 mutation, who are scheduled to undergo risk-reducing surgery to remove their ovaries and fallopian tubes. UPDATE: THIS STUDY HAS BEEN DISCONTINUED.

Clinicaltrials.gov identifier: NCT03382574

A Study in Hereditary Breast and Ovarian Cancer Families to Provide Men With Up To Date Information About the Personal Importance of Genetic Testing (GEM)

The Genetic Education for Men or GEM study, is a clinical trial evaluating educational tools for men from families in which a BRCA1/2 gene mutation has been identified. In order to identify untested men from BRCA1/2 families, we are seeking women who have received positive BRCA1/2 test results and have at least one untested male relative. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02957981

A Phase 2 Study of Nivolumab in Combination with Either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration-resistant Metastatic Prostate Cancer (CheckMate-9KD)

CheckMate-9KD is a clinical research study for men with metastatic prostate cancer (which means cancer that has spread) that no longer responds to treatments that lower testosterone. The purpose of this study is to compare three different combination therapies, each containing a drug called nivolumab and another anti-cancer drug. All three combination therapies are considered investigational, which means that they are not currently approved to treat men with metastatic prostate cancer. The study doctors want to learn more about which therapy is most effective in treating metastatic prostate cancer. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03338790

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

ATHENA is a study for women who are newly diagnosed with ovarian cancer. The goal of ATHENA is to look at whether giving maintenance therapy with different agents improves outcomes for women who have completed front-line treatment. UPDATE: THIS STUDY IS NO LONGER ENROLLING PATIENTS

Clinicaltrials.gov identifier: NCT03522246

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Men with advanced prostate cancer face difficult choices for treatment because of the nature of their disease and having limited options. This study will test the use of an innovative Registered Nurse-Community Patient Navigator team delivered interactive mHealth decision aid for patients with advanced prostate cancer to help facilitate informed shared decisions about anti-cancer treatment that affects their quality of life. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03327103

Safety and Efficacy of Olaparib Alone Or in Combination with Medication Targeting DNA Damaging Repair for Metastatic Triple Negative Breast Cancer

The purpose of this study is to learn the safety and effectiveness of the PARP inhibitor, olaparib as a single drug therapy compared with olaparib in combination with the new agent AZD6738 in patients with metastatic Triple-Negative Breast Cancer (TNBC). NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT03330847

Olive Oil for High Risk Breast Cancer Prevention

This study will evaluate the effect of hydroxytyrosol, a component of olive oil, on breast density in women who are at high risk for developing breast cancer. UPDATE: THIS STUDY IS NO LONGER ENROLLING PATIENTS.

Clinicaltrials.gov identifier: NCT02068092

Auricular Point Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors

Severe joint pain and muscle stiffness are common side effects of taking Aromatase Inhibitors. Aromatase inhibitor musculoskeletal symptoms have a negative effect on a woman's physical function and quality of life. Auricular point acupressure uses stimulation applied to points on the ear without using needles. This study will look at and test auricular (ear) point acupressure to manage aromatase-inhibitor-caused joint pain and muscle stiffness in breast cancer survivors.

Note: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03697200

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)

This study will look at how safe, effective and tolerable the oral PARP inhibitor Rucaparib is when used in combination with other anticancer agents in patients with advanced solid tumors, including triple-negative breast cancer, ovarian cancer or urothelial cancer. Note: This study has completed enrollment.

Clinicaltrials.gov identifier: NCT03992131

Study of Safety and Effectiveness of Motiva® Breast Implants

Note: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03579901

Additional Results on Clinicaltrials.gov
1000 results

Clinical Trial	Official Title
NCT07698314	A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
NCT06757192	CRC Screening in Unscreened Individuals 45-54
NCT06910657	IDOV-Immune for Advanced Solid Tumors
NCT06026657	Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
NCT06790693	A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT06599619	Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
NCT06966700	A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT05517811	Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
NCT05379595	A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
NCT06624644	A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
NCT06059118	Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT05627960	First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
NCT07064018	Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
NCT05376878	An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
NCT04318717	Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
NCT05696626	Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
NCT04752826	BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
NCT06129747	Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
NCT05984589	Personalized Health Self-Management Training for Colorectal Cancer Survivors
NCT04771520	Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
NCT05428735	The DRAGON 2 Trial
NCT06677190	Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
NCT07433660	WellSpan-THRIVE Cancer QOL Study
NCT01915225	Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
NCT06663072	Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
NCT06500169	Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
NCT06336902	Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
NCT07140172	Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07142551	Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
NCT05129605	Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT04570553	Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
NCT05396872	Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
NCT05625529	ExoLuminate Study for Early Detection of Pancreatic Cancer
NCT06228053	Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
NCT06518837	Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT06084481	Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
NCT05655494	A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
NCT07261631	Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
NCT06435429	A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
NCT04420702	Diffusion Basis Spectrum Imaging of the Prostate
NCT06632977	Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
NCT06334354	A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
NCT05882253	Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
NCT07502352	Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)
NCT03809585	Observational Study of Iris Tumors
NCT04512144	Mindfulness in Endometrial and Cervical Cancer
NCT06244004	FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
NCT05964504	Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
NCT07214532	Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
NCT05939414	An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
NCT07126548	A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
NCT06085833	ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
NCT06445738	Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
NCT05512208	A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
NCT05020574	Microbiome and Association With Implant Infections
NCT05968690	Naltrexone and Propranolol Combined With Immunotherapy
NCT07474090	Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
NCT07293585	Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
NCT07214610	Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
NCT07040891	A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials
NCT06314958	Stage II/III Colorectal Cancer Recurrence
NCT06922591	Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
NCT07733674	Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05879926	Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT05704283	3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
NCT07277413	A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
NCT07167446	Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
NCT07504588	Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
NCT06028022	Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
NCT06885697	Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
NCT04606446	Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT06856694	RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
NCT06966388	Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
NCT06638502	Safety of HRX215 in Patients After Minor and Major Liver Resection
NCT05020860	Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
NCT06807437	Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
NCT06055439	A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
NCT06130995	Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
NCT06138067	Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NCT06465966	UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning
NCT07114939	FTT PET/CT in Pancreatic Neuroendocrine Tumors
NCT07136428	Asciminib in HER2+ Breast Cancer Brain Metastases
NCT07622901	Fasting InTervention for Endometrial Cancer
NCT06070012	Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
NCT07022483	Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
NCT06178354	Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
NCT07227831	A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
NCT03897270	Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
NCT01530373	Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
NCT05557877	Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
NCT04485286	Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
NCT07736937	Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
NCT06302595	MRI Guided Prostate Biopsy
NCT06102902	Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
NCT06268665	Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
NCT06545045	Cognitive Rehabilitation Following Breast Cancer Treatment
NCT04172532	Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
NCT06813898	An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
NCT07723209	Radiation After No Axillary Nodal Sampling
NCT07164443	A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT05144698	RAPA-201 Therapy of Solid Tumors
NCT05854498	Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
NCT07030348	Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
NCT06582017	Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
NCT06585410	Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
NCT02610413	Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
NCT05005403	Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
NCT02610426	Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
NCT06150417	MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
NCT05797168	Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05692024	COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
NCT05710380	MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
NCT07018986	The MIND-BC Study: MIND Diet for Breast Cancer Cognition
NCT04421820	BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
NCT06651359	Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
NCT05652686	A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
NCT05429970	A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
NCT06413680	A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
NCT05134779	De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
NCT04824027	Breast Elasticity Imaging During Neoadjuvant Chemotherapy
NCT02064673	Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
NCT06984562	Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
NCT07006727	Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT04886986	Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
NCT06454383	Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
NCT07661966	Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade
NCT06063928	Confronting Cancer as a Community
NCT07419841	A Phase 1 Study of the Safety and Tolerability of CTX-10726
NCT06887205	Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
NCT06638294	Study in Patients With Breast Cancer Leptomeningeal Metastasis
NCT05045066	Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
NCT05921253	Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
NCT05588453	Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
NCT07066657	A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
NCT05174286	Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
NCT03011684	Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
NCT03842943	Neoadjuvant Combination Immunotherapy for Stage III Melanoma
NCT04946370	Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
NCT04861077	Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
NCT06380751	Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
NCT02253251	Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
NCT07491445	Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07220863	Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai
NCT04657068	A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT07117032	Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
NCT06945315	SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
NCT06643767	Evaluation of the Bexa Breast Examination
NCT07235293	A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
NCT02620852	Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NCT05386108	Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
NCT07200830	Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
NCT06545604	Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
NCT05774678	Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Tissue Nanomechanical Phenotype Evaluation
NCT06518564	Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
NCT05838716	Vitamin D for Prostate Endocrine Therapy
NCT05366699	LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
NCT06875128	Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
NCT05647564	PET/CT Characterization of Treatment Resistance
NCT05559164	Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
NCT07090148	Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
NCT05042687	Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NCT06600906	Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
NCT07817147	CREO - Microwave Ablation Feasibility Study
NCT06878547	VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
NCT07545811	Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
NCT07225946	A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07237594	IL-17 Blockade to Decrease irAEs (REPLAY)
NCT05287451	Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT07173751	ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
NCT05440929	Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
NCT07112053	A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
NCT06411795	Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
NCT06492070	Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
NCT05984888	Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
NCT06472661	FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
NCT07470853	A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
NCT04494945	Identifying and Caring for Individuals With Inherited Cancer Syndrome
NCT07162194	MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
NCT06004245	A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
NCT07645651	Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
NCT03608631	iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
NCT07213674	A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
NCT05503797	A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
NCT06136624	Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
NCT07087054	Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT06562192	Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT05739981	Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT05052671	ctDNA Assay in Patients With Resectable Pancreatic Cancer
NCT07218432	A Study of the TheraBionic P1 Device in Breast Cancer
NCT07454499	Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
NCT04370587	A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
NCT06677112	MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
NCT05123807	Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
NCT06757634	Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT05684367	Exercise to ReGain Stamina and Energy (The EXERGISE Study)
NCT05726292	A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
NCT07587957	Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors
NCT05498792	Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
NCT06065371	Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
NCT07060807	A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT01954992	Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
NCT01913106	HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
NCT04473833	Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
NCT07322094	CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
NCT05950945	Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
NCT06496256	Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
NCT06051695	A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
NCT07319195	Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
NCT07824583	A Study Evaluating a New Radiation Treatment Workflow (NGDS)
NCT06253494	Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
NCT06388122	DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
NCT05824975	A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
NCT05234177	Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
NCT04090567	Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
NCT05253651	A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT06463028	Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
NCT01950572	Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
NCT06665945	The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
NCT06631521	Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
NCT02402244	Project: Every Child for Younger Patients With Cancer
NCT03823144	Intravital Microscopy in Human Solid Tumors
NCT07287917	Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
NCT05687123	Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
NCT06040125	Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
NCT05239338	Preserving Fertility After Colorectal Cancer Study
NCT07220720	POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
NCT05241249	Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
NCT06957691	Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
NCT03659448	Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
NCT07029490	Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
NCT07379138	Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
NCT05384535	Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
NCT06995898	The Vanguard Study: Testing a New Way to Screen for Cancer
NCT06881992	A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
NCT05542407	ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
NCT05422911	Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
NCT07416552	A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
NCT07593092	Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors
NCT04990609	EUS-RFA PANCARDINAL-1 Trial
NCT04594187	Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
NCT07512271	Generative AI Patient Education Module for Breast Oncology
NCT04706663	Precision-Based Genomics in Prostate Cancer
NCT07739563	EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
NCT07659795	A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
NCT04503265	A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
NCT06526299	Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
NCT05978128	Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
NCT05716893	Study of Aerobic Training for People Receiving Treatment for Breast Cancer
NCT04799535	Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
NCT05869682	Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
NCT07085091	A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NCT05859074	A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
NCT07551596	Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
NCT04636710	Refining Local-Regional Therapy for IBC
NCT05379985	Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT05929768	Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT07391774	Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
NCT05515978	Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
NCT07529808	Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
NCT07690189	Study of NTB-928 in R/R OC
NCT07044310	5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
NCT07814248	A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
NCT07095517	Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NCT07505797	ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
NCT06366490	Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
NCT05746897	A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
NCT06922318	The COSMYC Trial (COmbined Suppression of MYC)
NCT07764133	Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer
NCT06297525	Study of STP938 (Dencatistat) in Advanced Solid Tumours
NCT07345676	Colorectal Cancer Screening Outreach
NCT07364071	Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
NCT07095114	A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NCT07209436	Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction
NCT07062016	Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT02743858	Lymphedema Surveillance Study
NCT05534438	A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
NCT06743126	SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
NCT07062965	A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT06819007	Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
NCT06139107	RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
NCT05053555	High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
NCT06099093	Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
NCT07628634	Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
NCT07225309	A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
NCT07278336	A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
NCT04703244	Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
NCT06659614	Prostate Tissue BioBank
NCT05780814	The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
NCT07493512	Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
NCT05624918	A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
NCT07454642	AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
NCT07115914	PSMA PET for Surveillance After Focal Therapy
NCT06698458	Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
NCT02732171	PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
NCT07024784	A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
NCT06730347	A Study of Lorigerlimab in Participants With Advanced Solid Tumors
NCT06774963	A Phase 1 Study of LNCB74 in Advanced Solid Tumors
NCT03977233	Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
NCT07383649	Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
NCT05530655	A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
NCT02871726	Transrectal Ultrasound Robot-Assisted Prostate Biopsy
NCT06425926	Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
NCT03567889	Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT06898333	Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
NCT07210086	Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
NCT05941520	Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT06617923	Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
NCT05107674	A Study of NX-1607 in Adults With Advanced Malignancies
NCT06242470	A Study of MGC026 in Participants With Advanced Solid Tumors
NCT05497024	Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
NCT06085313	Cancer Pain Management Using a Web-based Intervention
NCT01000259	Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
NCT07489287	GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT05846789	Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
NCT05766891	Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
NCT06586515	MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT05972343	COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
NCT06072612	Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT06173310	DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
NCT03947385	Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
NCT07594626	BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
NCT06756035	CT-95 in Advanced Cancers Associated With Mesothelin Expression
NCT07704918	Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
NCT06284590	Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
NCT05013255	Pioglitazone Therapy Targeting Fatigue in Breast Cancer
NCT04751435	Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
NCT07318324	Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
NCT07487168	Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
NCT05413850	Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
NCT07686250	Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery
NCT07040280	Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma
NCT07147231	Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
NCT03934905	Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
NCT07389967	Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
NCT06224673	ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
NCT05130801	A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
NCT06121453	Adherence Intervention in Patients With Metastatic Breast Cancer
NCT06022822	Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
NCT07318051	Sample Collection for Ongoing Research and Product Evaluation Study
NCT04523857	ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
NCT06892275	The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
NCT07032545	Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
NCT05490472	JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
NCT05608252	VS-6766+Abema+Fulv in Met HR+/HER- BC
NCT05743049	Collection of Circulating Biomarkers in Pancreatic Cancer
NCT07584226	A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
NCT06324240	Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
NCT06026410	KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
NCT05115474	Study of Screening Brain MRIs in Stage IV Breast Cancer
NCT07555210	Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
NCT07281768	Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
NCT00912717	Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT07094113	AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
NCT06559540	Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer
NCT07203378	Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
NCT06553885	Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
NCT00899626	Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
NCT06059963	A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
NCT04897321	B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
NCT04792684	Collection of Samples USOPTIVAL Study
NCT06576115	Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
NCT03564340	Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
NCT07027488	AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07468903	Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
NCT04683679	A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
NCT04986579	Scalp Cooling in MBC
NCT05483491	KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
NCT06075810	A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
NCT07109726	A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
NCT05826743	Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
NCT07059845	A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
NCT07184957	Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
NCT05941507	A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
NCT07231627	AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
NCT07222267	An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
NCT06799065	First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
NCT07143487	Family Communications After Genetic Testing
NCT06943521	A Study of MT-4561 in Patients With Various Advanced Solid Tumors
NCT05716516	STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
NCT06149481	Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
NCT05059444	ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT03671044	A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
NCT04893109	ATEMPT 2.0: Adjuvant T-DM1 vs TH
NCT07424547	Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
NCT07023887	Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
NCT07130903	Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
NCT06990542	Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer
NCT07044583	SAVE Trial: SAfe Opioid Use Video Education
NCT06262139	Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
NCT06923527	Circulating Tumor DNA
NCT06986083	A Study of Changes to Prostate Procedures
NCT06165302	Exercise in Prostate Cancer
NCT07071961	Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
NCT01000883	Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT04198766	Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
NCT04300556	A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
NCT07184970	PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
NCT06515470	Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
NCT05852041	rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
NCT07181161	Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
NCT03151629	International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT07405801	A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
NCT07402473	Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
NCT06756932	BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
NCT05225428	Video Education With Result Dependent dIsclosure
NCT05014399	Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
NCT07136181	Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
NCT04858334	APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
NCT05043012	Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
NCT06524895	Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery
NCT05765500	RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
NCT05748834	Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
NCT06723236	A Study of MGC028 in Participants With Advanced Solid Tumors
NCT02584244	Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
NCT07077239	Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
NCT03972657	A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
NCT04265872	Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
NCT05283330	Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
NCT07114601	A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT06908928	A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
NCT05549297	Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT04339374	Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
NCT07227168	A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
NCT07242118	Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management
NCT03686124	ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
NCT03067051	Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
NCT06845319	NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
NCT06515613	A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
NCT06893276	e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
NCT07318558	A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07281716	Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
NCT07723248	A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
NCT06865768	An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
NCT06696768	Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
NCT05501704	ETHAN - ET for Male BC
NCT06673017	PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06915168	CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
NCT04475640	Cancer Genetic Testing in Ethnic Populations
NCT05130606	CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
NCT07635147	Decision Support Tool for Patients With Advanced Breast Cancer
NCT06058377	Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
NCT07220512	The Better, Harder, Faster, Stronger Study
NCT04734730	Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
NCT06610539	PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
NCT07224009	Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
NCT07415564	Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
NCT04913285	A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT07042685	Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
NCT05280314	Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
NCT07032584	Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
NCT05752448	Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
NCT06195306	Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT06565052	The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
NCT04362826	Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer
NCT05242744	FTT PET/CT in Metastatic Prostate Cancer
NCT07544589	A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
NCT01766297	Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
NCT06733350	Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
NCT05150691	A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
NCT07224815	cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
NCT06682650	Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
NCT02926690	Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
NCT06726148	Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT05528133	Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
NCT04590326	A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
NCT05646316	Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
NCT07208084	Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer
NCT04816006	Breast Cancer, Reasoning, and Activity Intervention
NCT04841148	Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
NCT07759921	Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
NCT01185132	Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
NCT06067295	Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
NCT06073431	LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT04888975	A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
NCT04692675	Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04550845	Understanding of Genetics by Men at Risk for Prostate Cancer
NCT06182072	ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06085729	Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
NCT05307705	A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
NCT06574022	Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
NCT05902988	A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
NCT07169734	A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
NCT06806930	Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
NCT05655312	MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
NCT04489719	Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
NCT05315700	Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
NCT06940271	Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy
NCT05996107	Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
NCT00969111	Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
NCT07403981	Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
NCT05053971	Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
NCT07046585	Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
NCT05721976	With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
NCT06483048	MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
NCT07020117	A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
NCT06444815	A Study of VET3-TGI in Patients With Solid Tumors
NCT05112601	Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
NCT05288777	Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
NCT07332975	ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
NCT07500012	taVNS for Breast Cancer Pain and Symptom Management
NCT07643012	Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
NCT05627219	Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
NCT03541928	Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
NCT05877430	Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
NCT06095089	A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
NCT06931340	Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
NCT06276491	Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
NCT05056818	Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT07023289	A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
NCT06824818	Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
NCT06534918	Precise Oncology Interventions in Nutrition and Training (OnPoint)
NCT04692818	3D Ultrasound Breast Imaging
NCT07262138	Active Surveillance in Older Women With ER+ Breast Cancer
NCT07619521	Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
NCT07284849	A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT03354416	Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
NCT07094204	A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
NCT06293898	Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
NCT06298916	64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
NCT07436793	Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
NCT04526587	Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
NCT07621614	A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
NCT05667532	The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts
NCT04913064	Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
NCT07220239	Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NCT05564377	Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
NCT05989828	A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
NCT06941857	NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
NCT06172283	Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT07550088	BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
NCT07084779	Investigation of Impact of AI on Prostate Cancer Workflow
NCT02945579	Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
NCT06200259	Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
NCT06698146	Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
NCT07306559	A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
NCT07570979	A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
NCT07071896	A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors
NCT06896162	PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
NCT07386444	Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
NCT07406087	Navigation Intervention for Adolescent and Young Adult Cancer Survivors
NCT06148298	Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
NCT05216432	First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
NCT06377852	The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
NCT06555133	Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
NCT04174352	FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
NCT07504796	ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
NCT05789433	Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
NCT06943755	Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT07126158	Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
NCT05676255	The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
NCT06983743	A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
NCT06275126	Optimizing Surgical Decisions in Young Adults With Breast Cancer
NCT07427043	Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
NCT03448926	The PREDICT Registry:
NCT06168487	Telmisartan in Prostate Cancer
NCT03484299	Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
NCT06855654	Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
NCT07043270	24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
NCT02706561	Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
NCT05026983	Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
NCT05625659	Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NCT06589440	Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
NCT06312176	A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06603597	HER2-positive Breast Cancer Registry
NCT07216560	First-in-human Study of 7MW4911 in GI Cancer
NCT05546827	Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma
NCT07227077	Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
NCT06518057	Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
NCT06330064	A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
NCT06171139	Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
NCT07393867	Androgen-responsive POSLUMA-guided Intra-prostatic Boost
NCT07332000	A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
NCT07287098	A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
NCT04402151	Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
NCT07768436	A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
NCT06103864	A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
NCT07349537	Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
NCT06062745	Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
NCT04389281	X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
NCT03463954	Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
NCT06963905	Saci Nivo Rela for TNBC
NCT07084168	Multimedia Aid for Genetic Testing in Gynecologic Oncology
NCT06263088	EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
NCT06450873	Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery
NCT07303894	A Study of Isoquercetin in People With Ovarian Cancer
NCT00991094	Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
NCT04741997	Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
NCT05568680	SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
NCT06937996	Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
NCT06952504	A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT02381990	MRI/Ultrasound Fusion Guided Prostate Cryotherapy
NCT05593497	A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
NCT04986423	ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
NCT07765927	Exercise Oncology Clinic Pilot Feasibility Trial
NCT05620329	UNC Pleural Fluid Registry
NCT06878131	Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
NCT01503190	The Immune System's Response to Young Women's Breast Cancer
NCT07198724	ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
NCT07215988	Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
NCT06389786	Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
NCT06330805	Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
NCT06288113	Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
NCT07341503	The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
NCT06120283	BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT05559879	Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
NCT07283705	A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
NCT07080242	Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
NCT05006131	Pancreatic Cancer Screening for At-risk Individuals
NCT06075953	DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
NCT07218666	Zanzalintinib in Men With Aggressive Variant Prostate Cancer
NCT06695845	A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
NCT05698576	TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
NCT03802851	HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
NCT07218250	A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
NCT06682988	A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
NCT06949410	HER2 Vaccine for Locally Advanced Breast Cancer
NCT04510129	A Multicenter Cancer Biospecimen Collection Study
NCT07067788	B.Brilliant Revelation Comparision Study
NCT06218303	Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
NCT06997029	A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
NCT03137095	Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
NCT04169542	Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
NCT06378866	Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
NCT07542041	Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
NCT07546331	Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
NCT07543757	Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
NCT06037954	A Study of Mental Health Care in People With Cancer
NCT06926868	A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT05694559	Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NCT07851025	Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
NCT06800313	Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
NCT03832361	Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
NCT03860883	Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
NCT06099769	A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT07198074	Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
NCT06827613	A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
NCT02332668	A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
NCT06710288	A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
NCT07130708	Exploring the Potential of Robotic Telesurgery in Remote Settings
NCT03678025	Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
NCT05790213	Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
NCT06648434	MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT05232916	Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
NCT05225363	Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
NCT07635238	A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
NCT06216938	RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
NCT04683315	PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
NCT06982521	Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06084338	Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
NCT05088798	Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
NCT06586047	Breast Cancer PSMA PET
NCT06880055	Shield Post-Approval Study Protocol
NCT03675893	RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
NCT07730021	A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
NCT03449238	Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
NCT06300463	Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
NCT05935384	SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
NCT04641247	A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
NCT06864338	Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
NCT04969315	TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
NCT05903131	Uterine Preservation Via Lifestyle Transformation
NCT07413939	RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
NCT06795529	Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
NCT04545957	Jump: MR Simulation For Radiation Therapy Master Protocol
NCT05774951	A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
NCT05086692	A Beta-only IL-2 ImmunoTherapY Study
NCT07483307	A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
NCT04924075	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
NCT04929223	A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
NCT03769766	Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
NCT06239194	Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
NCT01521741	Prospective Screening for Breast Cancer-related Lymphedema
NCT06990880	A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
NCT04650256	Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
NCT04115254	Stereotactic Magnetic Resonance Guided Radiation Therapy
NCT07226856	BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
NCT07357597	An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
NCT05633654	Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT06179303	Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
NCT06203106	NYSCF Scientific Discovery Biobank
NCT04567706	A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
NCT06161506	Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
NCT06822530	A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
NCT06072807	Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
NCT06391034	Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
NCT07179809	Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
NCT06563388	Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
NCT05585788	Opioid Dispensing Device for Post-Operative Pain in Cancer Patients
NCT06896474	SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
NCT07406282	A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
NCT03452774	SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
NCT06437574	Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
NCT05464810	Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
NCT04763980	Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
NCT07146568	Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
NCT07450859	A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07276880	Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
NCT07772869	Uterine Lavage to Detect Ovarian Cancer Risk
NCT07492680	A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
NCT05484973	Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
NCT06202183	Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
NCT06492759	High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
NCT05054296	Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
NCT04923542	SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
NCT06047379	Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
NCT07219303	Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
NCT06487507	Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
NCT05867251	Study of AVZO-021 in Patients With Advanced Solid Tumors
NCT07120100	Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
NCT07162337	BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
NCT07085767	Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT05113537	Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
NCT06925737	A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT07264790	Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
NCT01365169	Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
NCT07025369	Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
NCT06956690	A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
NCT06997497	A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT03474913	Upright MRI for Prostate Cancer Screening
NCT07746713	A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
NCT04074720	Prospective Breast Cancer Biospecimen Collection
NCT07743190	A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)
NCT07311993	Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
NCT07436078	Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT06145633	Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
NCT07660055	Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
NCT05830058	Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
NCT05413421	Study of ORIC-944 in Patients With Metastatic Prostate Cancer
NCT06915025	Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
NCT04624555	The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
NCT04765150	Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT06245889	PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
NCT05361174	A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
NCT07629960	A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
NCT05946824	This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
NCT04371913	Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
NCT05590624	Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer
NCT07751159	Radiation Therapy Approaches for People With Prostate Cancer
NCT06502691	[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
NCT05848141	Rowing Following Breast Cancer Chemotherapy
NCT06500481	Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
NCT04812912	Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
NCT07590934	Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
NCT06830265	Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis
NCT07107334	A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
NCT04022616	Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
NCT07052214	PSMA PET Combined With MRI for the Detection of PCa
NCT06153836	Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
NCT06942104	Imaging of Solid Tumors Using 18F-TRX
NCT07677839	UHFUS Characterization of Normal Lymphatic Anatomy
NCT02674100	American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
NCT04985032	Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
NCT06795009	Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
NCT06488365	In Vivo Liquid Biopsy of Melanoma (Cytophone)
NCT06593431	Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
NCT06044857	PSMA PET Response Guided SabR in High Risk Pca
NCT05001477	Customized TULSA-PRO Ablation Registry
NCT03568630	Blood Markers of Early Pancreas Cancer
NCT04895709	A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT03692429	alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
NCT06613100	Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
NCT06169371	Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
NCT02478892	Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
NCT05784688	Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
NCT05979610	Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
NCT06952803	A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
NCT07164027	Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
NCT06910761	Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
NCT05464082	Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
NCT06705803	Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
NCT05761561	Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
NCT04779554	Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
NCT06115486	EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
NCT04852887	De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
NCT07361107	Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)
NCT04529044	177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
NCT06218914	Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
NCT05132504	Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
NCT06867484	Breast Re-irradiation After Second Ipsilateral Lumpectomy
NCT05898399	Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
NCT06225011	Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
NCT07285044	The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
NCT06100263	Breast Cancer Resiliency Through Exercise Program (B-REP)
NCT01042548	Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
NCT07157033	A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
NCT06326411	A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT06637306	Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
NCT06216249	Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
NCT04839614	Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
NCT06274047	PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
NCT00823654	Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
NCT04990921	Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
NCT06934538	First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT07202247	Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
NCT05491226	Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
NCT05519449	Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
NCT06230185	CtDNA Based MRD Testing for NAC Monitoring in TNBC
NCT07145255	Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
NCT06815497	Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
NCT02422641	Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
NCT06349590	Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
NCT07488923	A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
NCT06835569	A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT05548296	A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
NCT07211659	Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
NCT06888388	Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
NCT03990896	Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
NCT07564141	Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
NCT06237179	Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
NCT06958328	Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
NCT06517901	Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
NCT06492616	A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT07482384	Supporting Health Including Endocrine Treatment for Long Duration
NCT05719558	A Study of ASP1002 in Adults for Treatment of Solid Tumors
NCT06504147	A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
NCT05741164	Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
NCT02290834	Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NCT05914987	Determining Individualized Cancer Therapy in Pancreatic Cancer
NCT06112314	IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT07276529	Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
NCT04038619	Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
NCT07365995	A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT06940739	A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
NCT07069595	PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
NCT02843945	Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
NCT02610439	Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
NCT03551951	Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
NCT07148245	Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
NCT06989437	A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
NCT06538337	Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
NCT06937177	Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
NCT04474301	Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
NCT03701581	4-aminopyridine Treatment for Nerve Injury
NCT05819892	Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
NCT07348367	A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
NCT06272864	BostonGene and Exigent Genomic INsight Study
NCT04891068	BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
NCT04251052	A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NCT07704476	EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
NCT06466434	Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma
NCT05787834	Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
NCT05812807	Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
NCT05035836	A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
NCT04658303	Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
NCT06042569	Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
NCT06774027	Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
NCT03492151	Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
NCT06543537	Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
NCT06525766	Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
NCT06234423	A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
NCT05411718	A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
NCT04511013	A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
NCT06295159	Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
NCT05735080	Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT05534646	Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
NCT07407920	Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
NCT06559059	Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
NCT05505643	Cryoablation vs Lumpectomy in T1 Breast Cancers
NCT01961713	Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
NCT03861676	Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
NCT06826768	A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
NCT05126290	CTNNA1 Familial Expansion Study
NCT04890613	Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
NCT05764720	Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
NCT06369246	PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
NCT06946225	ACTengine® IMA203 Combined With mRNA-4203
NCT06682390	Role of Race in Nutritional Approach in Men on ADT
NCT07054723	Surviving Daily Life
NCT03572374	Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
NCT03536897	IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
NCT05795101	TRUDI: TDXD+Durva in HER2+/Low IBC
NCT06760507	Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NCT07574671	Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer
NCT07096999	SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
NCT05142800	Screening For BCRL In Targeted Therapy For Breast Cancer
NCT07655934	A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
NCT04797039	MRI-Guided Cryoablation for Focal Native Prostate Cancer
NCT06663319	A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
NCT00949819	Active Surveillance for Cancer of the Prostate (ASCaP)
NCT07548164	Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT07411599	Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
NCT04511039	Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
NCT06600698	Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
NCT06843447	A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
NCT05659797	FES BPET-DBT in Newly Diagnosed Breast Cancer
NCT07223047	A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
NCT06710548	REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
NCT04589468	Researching the Effect of Exercise on Cancer
NCT07455058	Water Vapor Ablation for Prostate Cancer: Long-Term Registry
NCT05989347	Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
NCT06648278	Patient Care Outreach, Navigation, Technology and Support 2.0
NCT03424850	Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
NCT07393906	Colorectal Cancer Prevention Research Study: Eat Right, Screen Right
NCT06930755	Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
NCT05412225	A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
NCT07563738	A 2-part Phase 1/2 Open-label Trial on ODM-212
NCT07227038	Living Well With Advanced Breast Cancer
NCT06263543	Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
NCT07067138	A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT07128355	Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
NCT07360314	Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
NCT07277738	Precision Supplemental Imaging in Women With Dense Breasts
NCT07543055	A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
NCT07504835	GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
NCT06764940	A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
NCT07219147	177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT06533826	TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
NCT06961955	5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
NCT07076147	Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
NCT07646847	A Study of a Side Effects and Resource Navigation Program for People With Cancer
NCT04188535	Serial MRI Scans During Radiation Therapy
NCT03454035	Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
NCT07221825	Low-Count Quantitative SPECT for Men Treated With Radium-223
NCT07719361	A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07790718	Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
NCT07310420	A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
NCT07226713	Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
NCT07181473	A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
NCT03418961	S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
NCT06814496	Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
NCT07226427	A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
NCT05660083	Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
NCT06545682	Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
NCT07444541	ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
NCT07340541	Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
NCT07069556	ColoSense Post-Approval Study
NCT00001823	Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT05377996	A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
NCT06529523	Tislelizumab in People With Colorectal Cancer
NCT04725903	Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
NCT06040541	Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
NCT03422198	Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
NCT07029399	A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
NCT06517212	Tirzepatide Weight Loss for MRD+ Early Breast Cancer
NCT06365619	Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
NCT07549412	A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT06763328	Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
NCT06106477	Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
NCT06111781	The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
NCT05691465	Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
NCT07030257	Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
NCT07623941	CUIMC Focal Therapy Registry
NCT03260842	Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
NCT07226986	A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
NCT06738303	Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
NCT06100705	Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
NCT06030622	Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer
NCT05952453	Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
NCT06194929	Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
NCT05607095	A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
NCT03539822	Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
NCT07286331	A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
NCT03054584	Genetic Basis of Melanocytic Nevi
NCT06974604	Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
NCT04333706	A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT06365905	Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
NCT05915442	Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
NCT04239573	Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
NCT07005154	A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT06736054	A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
NCT05693766	Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
NCT04981119	Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
NCT06612281	Evaluation of Gixam's Performance in a FIT Negative Population
NCT07249775	A First-in-Human Study of FID-022 in Solid Tumor Patients
NCT06342401	Early Onset Colorectal Cancer Detection
NCT06305312	Community Services Navigation to Advance Health Equity in Breast Cancer Screening
NCT07280312	Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
NCT06412198	A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
NCT02016248	SBRT Boost for Unfavorable Prostate Cancer'
NCT06332755	Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
NCT07776691	A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
NCT04230109	Sacituzumab Govitecan In TNBC
NCT04768426	Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
NCT05990426	Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
NCT07049276	The Multicentre Selective Lymphadenectomy Trial - 3
NCT06780176	A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
NCT07219238	Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
NCT04048278	Lidocaine Infusion in Pancreatic Cancer
NCT06534125	Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
NCT06105749	Biennial CEM in Women With a Personal History of Breast Cancer
NCT04778449	Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
NCT07070726	UNTOLD Ovarian Cancer Unmet Needs Survey
NCT04916990	Improving Care for Rural Patients With Solid Tumors
NCT07325721	Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT07562152	Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT06235697	Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
NCT05879913	ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NCT06270043	Focal Therapy for Localized Prostate Cancer
NCT06340568	A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06451497	This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
NCT03250078	A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
NCT07186296	EXoPERT EMERALD Clinical Study
NCT07594015	Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
NCT06860815	Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
NCT04167969	The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
NCT05469269	Cleveland African American Prostate Cancer Project
NCT07652242	Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
NCT07804186	Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
NCT05818683	A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
NCT05384496	Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

Search Results: (30 results)

Phase 1/1b Study of Oral Drug PMD-026 in People with Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

A Study of EDP1503 in Patients With Colorectal or Triple Negative Breast Cancer or Cancer That Came Back After Treatment with a Checkpoint Inhibitor

RESTORE: A virtual study comparing 2 digital apps to improve mental and physical well-being of patients with stage I – 3 cancer

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Mobile Mindfulness Meditation Intervention to Improve Neuropathy in Cancer Survivors

Niraparib + Ipilimumab or Nivolumab in Pancreatic Cancer that Has Not Progressed After Platinum Chemotherapy (Parpvax)

Parenting Adolescent-Aged Children While Managing a Parental Cancer Diagnosis – Share Your Story

Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors

Nous-209 Genetic Vaccine for the Treatment of Microsatellite -High (MSI-H) Colorectal, Gastric and Gastro-esophageal junction Tumors

A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3)

Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS)

A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment with Immune Checkpoint Inhibitors (QUILT-3.055)

Safety and Efficacy of Olaparib Combined with Agents Targeting DNA Damage Repair Compared to Olaparib Alone

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden

A Study of Nivolumab in Selected Uterine Cancer Patients

GENetic Education Risk Assessment and TEsting Study (GENERATE)

A Study in Advanced Breast Cancer Patients with BRCA 1/2 Mutations Evaluating Olaparib alone or in Combination with Atezolizumab

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

PHACT Study: Population Health and Cancer Testing

Pilot Study of Denosumab in BRCA1 or BRCA2 Mutation Carriers Scheduling Risk-Reducing Salpingo-Oophorectomy

A Study in Hereditary Breast and Ovarian Cancer Families to Provide Men With Up To Date Information About the Personal Importance of Genetic Testing (GEM)

A Phase 2 Study of Nivolumab in Combination with Either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration-resistant Metastatic Prostate Cancer (CheckMate-9KD)

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Safety and Efficacy of Olaparib Alone Or in Combination with Medication Targeting DNA Damaging Repair for Metastatic Triple Negative Breast Cancer

Olive Oil for High Risk Breast Cancer Prevention

Auricular Point Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)

Study of Safety and Effectiveness of Motiva® Breast Implants

Additional Results on Clinicaltrials.gov
1000 results

Sponsored By

Knowledge Can Save Lives

Search Results: (30 results)

Additional Results on Clinicaltrials.gov 1000 results

Sponsored By

Knowledge Can Save Lives

Additional Results on Clinicaltrials.gov
1000 results